Back to search

Article

CDCA5 is a potent therapeutic target of clear cell renal cell carcinoma

2022-10-06

Abstract excerpt

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer in adult, and patients with advanced ccRCC are facing limited treatment options. Cell division cycle associated 5 (CDCA5), a key regulator for segregating sister chromatids in cell cycle, has been increasingly reported for a potential therapeutic target in multiple human cancers. However, the functional roles of CDCA5 in ccRCC remain...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fd949ff0-40d9-5e1e-ba37-338b9c7de34c
DOI
10.21203/rs.3.rs-2101665/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CDCA5 is a potent therapeutic target of clear cell renal cell carcinomaDOI 10.21203/rs.3.rs-2101665/v1
Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinomaSemantic proximity
Loss of CDCA5 Promotes Cell Apoptosis by Activating the DNA Damage Response in Clear Cell Renal Cell CarcinomaSemantic proximity
CDCA7: A Comprehensive Pan-Cancer Analysis Reveals its Prognostic Significance, Immune Correlations, and Therapeutic PotentialSemantic proximity
High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunitySemantic proximity
UBE2C contributes to malignant phenotypes in clear cell renal cell carcinoma via cell cycle and apoptosis regulation.Semantic proximity
Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinomaSemantic proximity
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathwaySemantic proximity
Overexpression of PLCG2 and TMEM38A inhibit tumor progression in clear cell renal cell carcinomaSemantic proximity
PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosisSemantic proximity
Downregulation of ENPP4 Is Associated with Poor Prognosis and Enhanced Malignant Phenotypes in Clear Cell Renal Cell CarcinomaSemantic proximity
CORO6 Promotes Cell Growth and Invasion of Clear Cell Renal Cell Carcinoma via Activation of WNT SignalingSemantic proximity
The tumor promoter role and molecular mechanism of C8orf76/CALB2 axis in clear cell renal cell carcinomaSemantic proximity
Select a neighboring publication to make it the new centre.